glp-1 gestational diabetes Drug Discontinuation Raises Pregnancy Risks | Fertility Plus posted on the topic Understanding GLP-1 receptor agonists and

For clinicians, GLP-1 RAs may be a pragmatic consideration in HS management where weight loss is a goal and comorbid metabolic risk is present, pending confirmatory evidence

Due to its extended activity profile and modified structure, IGF-1 LR3 is often selected for research applications that focus on long-duration signaling studies, receptor-binding dynamics, and controlled investigation of growth factorassociated biochemical pathways

PMCID: PMC9556320

Downen et al

Schultz et al., 1997)

Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes 2024. American Diabetes Association, December 11, 2023